Immunotherapy in advanced anal cancer: Is the beginning of a new era?-Reference-Cited by-同舟云学术

Immunotherapy in advanced anal cancer: Is the beginning of a new era?

Published:2022-04 Issue: Volume:105 Page:102373
ISSN:0305-7372
Container-title:Cancer Treatment Reviews
language:en
Short-container-title:Cancer Treatment Reviews

Author:

Ciardiello Davide,Guerrera Luigi Pio,Maiorano Brigida Anna,Parente Paola,Latiano Tiziana Pia,Di Maio Massimo,Ciardiello Fortunato,Troiani Teresa,Martinelli Erika,Maiello Evaristo

Publisher

Elsevier BV

Subject

Radiology, Nuclear Medicine and imaging,Oncology,General Medicine

Reference70 articles.

1. Anal cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up☆;Rao;Ann Oncol.,2021

2. Anal squamous cell carcinoma - State of the art management and future perspectives;Martin;Cancer Treat Rev.,2018

3. Squamous cell anal cancer: Management and therapeutic options;Pessia;Ann Med Surg (Lond),2020

4. Research on Anal Squamous Cell Carcinoma: Systemic Therapy Strategies for Anal Cancer;Carr;Cancers (Basel),2021

5. Immunotherapy in Anal Cancer;Phuong;Curr Oncol Rep,2020

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Anal carcinoma - exploring the epidemiology, risk factors, pathophysiology, diagnosis, and treatment;World Journal of Experimental Medicine;2024-09-20

2. Management of Metastatic Anal Cancer;Surgical Oncology Clinics of North America;2024-09

3. PD-L1 expression in squamous cervical carcinomas of Mozambican women living with or without HIV;Scientific Reports;2024-06-05

4. Combining chemotherapy and immunotherapy for advanced anal cancer: are we ready?;The Lancet Oncology;2024-04

5. Genetically light-enhanced immunotherapy mediated by a fluorinated reduction-sensitive delivery system;Biomaterials;2024-03